All In Biotech

Drug Trial Radar · NCT04672733

Hizentra® in Inflammatory Neuropathies - pHeNIx Study

Last checked: Nov 19, 2026Latest source record: Jan 7, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Jun 10, 2022

Primary completion

Dec 2027

Study completion Dec 2027

Sponsor

Lead sponsor
CSL BehringIndustry
Sponsor type
Industry
First posted
Dec 17, 2020

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The pHeNIx study, a national multicentre prospective non-interventional study, should help to describe the conditions of use for Hizentra® and the methods for switching from the IV to SC route in everyday practice, together with the tolerability and efficacy of treatment, which is monitored using a patient application (PRO: Patient-Reported Outcomes).

Conditions

  • Chronic Inflammatory Demyelinating Polyneuropathy

Interventions

  • HizentraBiological

    Solution for injection for subcutaneous use

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Length of time of Continuation of treatmentTime frame: up to 12 months

Locations

27 sites in 1 country. Site status is shown where the registry gives one.

  • CHU Amiens Picardie 1

    Amiens, France · Not yet recruiting

  • CHU Angers

    Angers, France · Recruiting

  • Hôpital privé de La Casamance

    Aubagne, France · Recruiting

  • CH Bayonne

    Bayonne, France · Recruiting

  • Hôpital Pellegrin

    Bordeaux, France · Recruiting

  • CHRU Brest

    Brest, France · Recruiting

  • Hôpital Henri Mondor

    Créteil, France · Recruiting

  • Hôpital Bicêtre

    Le Kremlin-Bicêtre, France · Recruiting

  • CH Libourne

    Libourne, France · Recruiting

  • Hôpital Roger Salengro, CHU Lille

    Lille, France · Recruiting

  • Hôpital Dupuytren

    Limoges, France · Recruiting

  • Hôpital Pierre Wertheimer,HCL

    Lyon, France · Recruiting

  • Hôpital de la Timone

    Marseille, France · Recruiting

  • CHU Montpellier

    Montpellier, France · Recruiting

  • CHRU Nancy

    Nancy, France · Recruiting

  • CHU Nantes

    Nantes, France · Recruiting

  • Hôpital Pasteur

    Nice, France · Recruiting

  • Hôpital Lariboisière

    Paris, France · Recruiting

  • La Pitié-Salpêtrière

    Paris, France · Recruiting

  • CHU Poitiers

    Poitiers, France · Recruiting

  • Centre hospitalier privé Saint Grégoire

    Rennes, France · Recruiting

  • Hôpital Charles Nicolle

    Rouen, France · Recruiting

  • CHU Saint-Etienne

    Saint-Etienne, France · Recruiting

  • CHU de Strasbourg

    Strasbourg, France · Not yet recruiting

  • CHU Toulouse

    Toulouse, France · Not yet recruiting

  • CHR Tours

    Tours, France · Recruiting

  • CH de Valence

    Valence, France · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.